Kevin D Pavelko

Jul 31, 2023 | nature.com | Madison L. Doolittle |Dominik Saul |Kevin D Pavelko |Joshua N Farr |David Monroe

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

May 26, 2023 | frontiersin.org | Manoj K Pandey |Kevin D Pavelko

Cancer immunotherapy has emerged as a promising treatment strategy for various types of cancers (1). However, the success of immunotherapy largely depends on the ability of the immune system to recognize and eliminate cancer cells. Inflammatory mediators play a crucial role in modulating the immune response to cancer cells.